Sort   by:  
 Page size 
Alzheimer's disease causes a progressive dementia that currently affects over 35 million individuals worldwide and is expected to affect 115 million by 2050 (ref. 1). There are no cures or disease-modifying therapies, and this may be due to our inability to detect the disease before it has progresse...
2014-03-09 | MTBLS72 | MetaboLights
Using a high-end mass spectrometry, we screened phosphoproteins and phosphopeptides in four types of Alzheimer's disease (AD) mouse models and human AD postmortem brains. We identified commonly changed phosphoproteins in multiple models and also determined phosphoproteins related to initiation of Ab...
ORGANISM(S): Mus musculus (Mouse) 
2014-09-10 | PXD001292 | Pride
Obesity during preclinical Alzheimer's disease development exacerbates brain metabolic decline
Sort   by:  
 Page size